New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
08:36 EDTSSNLF, MRK, BIIBMerck, Samsung Bioepis enter collaboration agreement
Merck (MRK) and Samsung Bioepis, a joint venture between Samsung (SSNLF) Biologics and Biogen (BIIB), announced that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon. Under the terms of the agreement, the companies will collaborate on clinical development, regulatory filings and manufacturing. If approved, Merck will commercialize this candidate. This collaboration builds on the agreement made by the two companies in February 2013 to develop and commercialize multiple biosimilar candidates.
News For MRK;SSNLF;BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 14, 2015
05:46 EDTSSNLFReport: Samsung to hold off release of flexible tablets in 2015, DigiTimes says
Subscribe for More Information
April 13, 2015
08:58 EDTMRKMerck may have positive read through from briefing docs, says SunTrust
Subscribe for More Information
06:09 EDTSSNLFSamsung semiconductor CapEx to reach $15B in 2015, DigiTimes reports
Samsung's semiconductor capital spending is expected to reach a record $15B in 2015, reports DigiTimes Research. The company's CapEx for system ICs is expected to reach $4B, mainly to finance the commencement of its Line-17 fab in Hwasong and a buildup of its plant in Austin, Texas. Reference Link
April 9, 2015
09:25 EDTMRK, BIIBPiper Jaffray pharmaceuticals analysts hold an analyst/industry conference call
Subscribe for More Information
07:27 EDTBIIBBiogen PML death case previously reported, says Deutsche Bank
Subscribe for More Information
07:23 EDTBIIBDoctors report case of fatal PML in patient treated with Tecfidera to NEJM
Subscribe for More Information
06:02 EDTSSNLFSamsung sees record shipmnents for Galaxy S6 smartphones, Reuters reports
Subscribe for More Information
April 8, 2015
07:33 EDTMRKAdvaxis, Merck begin enrollment in Phase 1/2 of ADJX-PSA with Keytruda
Advaxis (ADXS) and Merck (MRK) announced that enrollment has initiated in the Phase 1/2 clinical trial evaluating the combination of ADXS-PSA, an investigational Lm-LLO immunotherapy, and Keytruda, the first anti-PD-1 therapy approved in the United States, in patients with previously treated, metastatic castration-resistant prostate cancer, or mCRPC. The clinical trial, KEYNOTE-046, is the first-in-human study of Advaxis's lead Lm-LLO immunotherapy candidate for prostate cancer. It is the second study initiated to evaluate the use of KEYTRUDA in the treatment of advanced prostate cancer. ADXS-PSA and KEYTRUDA are members of a class of cancer treatments known as immuno-oncology therapies. Data from preclinical studies suggest that Advaxis Lm-LLO immunotherapies in combination with a PD-1 antibody may lead to an enhanced anti-tumor immune response. The results from KEYNOTE-046 will determine the future clinical development program for the combination.
07:24 EDTBIIBNeurotechnology Industry Organization to hold a conference
Subscribe for More Information
07:04 EDTMRKMerck's investigational Hep C therapy granted breakthrough therapy designations
Subscribe for More Information
06:15 EDTSSNLFSamsung rely on new phones to raise mobile profit margins, WSJ says
Subscribe for More Information
April 7, 2015
07:31 EDTBIIBBiogen to present data on neurological disease therapies at AAN meeting
Subscribe for More Information
07:14 EDTBIIB, MRKEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.
06:46 EDTSSNLFApple Pay, Google Wallet could see competition from CurrentC, Macworld says
Subscribe for More Information
April 6, 2015
19:49 EDTSSNLFSamsung sees Q1 operating profit KRW 5.9T, Bloomberg reports
Subscribe for More Information
11:10 EDTSSNLFNVIDIA reports favorable ITC ruling in patent fight with Qualcomm, Samsung
Subscribe for More Information
10:56 EDTSSNLFSamsung comments on smartphone durability test conducted by SquareTrade
Subscribe for More Information
10:39 EDTSSNLFQualcomm falls amid uncertainty about content in flagship Samsung phone
Subscribe for More Information
06:11 EDTSSNLFSamsung expected to win A9 chip orders for next iPhone, Bloomberg reports
Subscribe for More Information
06:07 EDTSSNLFSamsung uses internally developed wireless modem in Galaxy S6, WSJ reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use